Engineering Sweetness After Sucrose · Molecular Design, Enzymatic Bioconversion, Rare Sugars, Sweet Proteins and the European Regulatory Frontier
Sugar reduction is commonly approached as a substitution problem: the technologist removes sucrose, selects a high-intensity sweetener and restores sweetness until the analytical specification has been met. This interpretation is inadequate because sucrose performs at least four simultaneous functions in foods: sensory signalling, bulk and osmotic structuring, physicochemical control, and participation in chemical reactions during processing. Contemporary ingredient biotechnology offers a more complex repertoire, comprising highly purified steviol glycosides manufactured through enzymatic conversion, low-abundance monosaccharides such as D-tagatose and D-allulose, fermentation-derived polyols, and intensely sweet proteins. These ingredient families cannot be treated as interchangeable. Their metabolic fate, sweetness kinetics, solvent behaviour, thermal robustness, microbiological implications and legal identities are distinct. In 2026, a systematic review of 20 controlled human trials involving 1,033 participants reported attenuation of acute postprandial glycaemic responses after allulose or tagatose exposure but did not establish consistent benefits for longer-term lipid or body-composition outcomes.
Authors
- Jose Manuel López (ORCID: https://orcid.org/0009-0006-9238-0080)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-18
- DOI
- https://doi.org/10.5281/zenodo.24340160
- Primary Topic
- Biochemical Analysis and Sensing Techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00